Skip to content

Headache Inducing Effect of Cromakalim in Migraine Patients

The Effects of Levcromakalim on Cerebral Hemodynamic in Migraine Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03228355
Enrollment
16
Registered
2017-07-24
Start date
2017-05-24
Completion date
2017-11-30
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Migraine

Keywords

Levcromakalim

Brief summary

To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.

Interventions

To investigate the role of Levcromakalim on cerebral hemodynamic in migraine patients

DRUGSaline

To investigate the role of levcromakalim compared with saline cerebral hemodynamic in migraine patients.

Sponsors

Danish Headache Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Migraine patients of both sexes. * 18-60 years. * 50-90 kg. * Women of childbearing potential must use adequate contraception.

Exclusion criteria

* Headache less than 48 hours before the tests start * Daily consumption of drugs of any kind other than oral contraceptives * Pregnant or nursing women. * Cardiovascular disease of any kind, including cerebrovascular diseases.

Design outcomes

Primary

MeasureTime frameDescription
Cerebral hemodynamicBefore (-10 min) and after infusion (+2 hours) of levcromakalim compared with before and after infusion of salineChange on Media cerebri arterie.
HeadacheBefore (-10 min) and after infusion (+12 hours) of levcromakalim compared with before and after infusion of salineOccurrence of headache.
Migraine attackBefore (-10 min) and after infusion (+12 hours) of levcromakalim compared with before and after infusion of salineOccurrence

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026